BACKGROUND: Solitary fibrous tumors of the pleura (SFTPs) are infrequent neoplasms with no standardized criteria to predict risk of recurrence after curative surgery. The aim of the present study is to validate a recently proposed recurrence score in a large European cohort of patients with SFTP. METHODS: Validation of a previously published scoring system was assessed in a population of 113 patients who underwent complete resection of SFTPs. Patients were scored according to the pleural origin, morphology, size, hypercellularity, presence of necrosis or hemorrhage, and number of mitoses in their SFTPs. Receiver operating characteristic curves were plotted for the score. Time to recurrence analysis was performed using the Kaplan-Meier and Cox proportional hazards methods. RESULTS: After a mean follow-up of 13.2 ± 7.3 years, there were nine recurrences (8.0%). Score performance to predict recurrence was as follows: sensitivity = 78%, specificity = 74%, positive likelihood ratio = 3.0, and negative likelihood ratio = 0.3. A cutoff of 3 points was used to classify 79 patients (69.9%) at low risk and 34 patients (30.1%) at high risk for recurrence. A high-risk classification was significantly associated with more recurrences during follow-up (P = .004), worse overall survival (P = .0008), more extensive lung resections (P = .001), and the use of adjuvant therapies (P = .009). The present score outperformed England's criteria (P = .049) and de Perrot classification (P < .001) when predicting SFTP recurrence. CONCLUSIONS: The proposed scoring system, which combines common clinical and histologic features of resected SFTPs, remains predictive of recurrence in a separate patient population. The simple score may guide the postoperative surveillance of this uncommon tumor.
BACKGROUND: Solitary fibrous tumors of the pleura (SFTPs) are infrequent neoplasms with no standardized criteria to predict risk of recurrence after curative surgery. The aim of the present study is to validate a recently proposed recurrence score in a large European cohort of patients with SFTP. METHODS: Validation of a previously published scoring system was assessed in a population of 113 patients who underwent complete resection of SFTPs. Patients were scored according to the pleural origin, morphology, size, hypercellularity, presence of necrosis or hemorrhage, and number of mitoses in their SFTPs. Receiver operating characteristic curves were plotted for the score. Time to recurrence analysis was performed using the Kaplan-Meier and Cox proportional hazards methods. RESULTS: After a mean follow-up of 13.2 ± 7.3 years, there were nine recurrences (8.0%). Score performance to predict recurrence was as follows: sensitivity = 78%, specificity = 74%, positive likelihood ratio = 3.0, and negative likelihood ratio = 0.3. A cutoff of 3 points was used to classify 79 patients (69.9%) at low risk and 34 patients (30.1%) at high risk for recurrence. A high-risk classification was significantly associated with more recurrences during follow-up (P = .004), worse overall survival (P = .0008), more extensive lung resections (P = .001), and the use of adjuvant therapies (P = .009). The present score outperformed England's criteria (P = .049) and de Perrot classification (P < .001) when predicting SFTP recurrence. CONCLUSIONS: The proposed scoring system, which combines common clinical and histologic features of resected SFTPs, remains predictive of recurrence in a separate patient population. The simple score may guide the postoperative surveillance of this uncommon tumor.
Authors: Benoit Lahon; Olaf Mercier; Elie Fadel; Maria Rosa Ghigna; Boriana Petkova; Sacha Mussot; Dominique Fabre; Thierry Le Chevalier; Philippe Dartevelle Journal: Ann Thorac Surg Date: 2012-06-13 Impact factor: 4.330
Authors: Luis F Tapias; Mari Mino-Kenudson; Hang Lee; Cameron Wright; Henning A Gaissert; John C Wain; Douglas J Mathisen; Michael Lanuti Journal: Eur J Cardiothorac Surg Date: 2012-12-11 Impact factor: 4.191
Authors: Karen M Harrison-Phipps; Francis C Nichols; Cathy D Schleck; Claude Deschamps; Stephen D Cassivi; Paul H Schipper; Mark S Allen; Dennis A Wigle; Peter C Pairolero Journal: J Thorac Cardiovasc Surg Date: 2009-07 Impact factor: 5.209
Authors: Melissa L Rosado-de-Christenson; Gerald F Abbott; H Page McAdams; Teri J Franks; Jeffrey R Galvin Journal: Radiographics Date: 2003 May-Jun Impact factor: 5.333
Authors: Giuseppe Cardillo; Luigi Carbone; Francesco Carleo; Nicola Masala; Paolo Graziano; Antonio Bray; Massimo Martelli Journal: Ann Thorac Surg Date: 2009-11 Impact factor: 4.330
Authors: Laura Schirosi; Sylvie Lantuejoul; Alberto Cavazza; Bruno Murer; Pierre Yves Brichon; Mario Migaldi; Giuliana Sartori; Alessandro Sgambato; Giulio Rossi Journal: Am J Surg Pathol Date: 2008-11 Impact factor: 6.394
Authors: Armita Bahrami; Seungjae Lee; Inga-Marie Schaefer; Jennifer M Boland; Kurt T Patton; Stanley Pounds; Christopher D Fletcher Journal: Mod Pathol Date: 2016-08-26 Impact factor: 7.842
Authors: Bahil Ghanim; Sebastian Hess; Pietro Bertoglio; Ali Celik; Aynur Bas; Felicitas Oberndorfer; Franca Melfi; Alfredo Mussi; Walter Klepetko; Christine Pirker; Walter Berger; Imrich Harmati; Attila Farkas; Hendrik Jan Ankersmit; Balazs Dome; Janos Fillinger; Clemens Aigner; Balazs Hegedus; Ferenc Renyi-Vamos; György Lang Journal: Sci Rep Date: 2017-10-02 Impact factor: 4.379
Authors: P Schöffski; I Timmermans; D Hompes; M Stas; F Sinnaeve; P De Leyn; W Coosemans; D Van Raemdonck; E Hauben; R Sciot; P Clement; O Bechter; B Beuselinck; F J S H Woei-A-Jin; H Dumez; P Nafteux; T Wessels Journal: Sarcoma Date: 2020-03-26